Literature DB >> 2532701

Carbonic anhydrase III and collagen markers in serum following cross-country skiing.

T E Takala1, J J Vuori, P J Rahkila, E O Hakala, J A Karpakka, M J Alen, Y S Orava, H K Väänänen.   

Abstract

Protein leakage from type I skeletal muscle cells and collagen synthesizing cells were studied during a 24-h cross-country skiing relay in eight men using serum carbonic anhydrase III (S-CA III) and serum galactosylhydroxylysyl glucosyltransferase (S-GGT) as the respective specific marker proteins. Serum aminoterminal propeptide of type III procollagen (S-Pro(III)-N-P) was used as an indicator of type III collagen synthesis and serum creatine kinase (S-CK) as a nonspecific muscular marker. S-CK, S-CA III, and S-GGT were increased immediately following the skiing relay by 870%, 640%, and 40%, respectively. No significant change was observed in the concentration of S-Pro(III)-N-P following the exercise. A high positive correlation (rs = 0.92, P less than 0.01) was found between the increase in S-CA III and S-CK, whereas no correlation was observed between these muscular markers and S-GGT. The results suggest leakage from type I skeletal muscle cells and collagen synthesizing cells as a consequence of prolonged cross-country skiing, but there seems to exist no dependence between acute responses in muscular and connective tissue cells to exercise.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2532701

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  2 in total

1.  Training-induced changes in peritendinous type I collagen turnover determined by microdialysis in humans.

Authors:  H Langberg; L Rosendal; M Kjaer
Journal:  J Physiol       Date:  2001-07-01       Impact factor: 5.182

2.  Type I collagen synthesis and degradation in peritendinous tissue after exercise determined by microdialysis in humans.

Authors:  H Langberg; D Skovgaard; L J Petersen; J Bulow; M Kjaer
Journal:  J Physiol       Date:  1999-11-15       Impact factor: 5.182

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.